Cargando…

Extracellular S100A4 as a key player in fibrotic diseases

Fibrosis is characterized by fibroblast activation, extracellular matrix (ECM) accumulation and infiltration of inflammatory cells that sometimes leads to irreversible organ dysfunction. Considerable evidence now indicates that inflammation plays a critical role in the initiation and progression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhenzhen, Li, Yanan, Liu, Shuangqing, Qin, Zhihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294136/ https://www.ncbi.nlm.nih.gov/pubmed/32307910 http://dx.doi.org/10.1111/jcmm.15259

Ejemplares similares

S100A4(+) Macrophages Are Necessary for Pulmonary Fibrosis by Activating Lung Fibroblasts
por: Li, Yanan, et al.
Publicado: (2018)

Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
por: Samarelli, Anna Valeria, et al.
Publicado: (2021)

S100A4 blockage alleviates agonistic anti-CD137 antibody-induced liver pathology without disruption of antitumor immunity
por: Zhang, Jinhua, et al.
Publicado: (2018)

S100A4 promotes hepatocellular carcinogenesis by intensifying fibrosis-associated cancer cell stemness
por: Li, Yanan, et al.
Publicado: (2020)

S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation
por: Liu, Shuangqing, et al.
Publicado: (2021)

Extracellular vesicles: catching the light of intercellular communication in fibrotic liver diseases
por: Li, Yijie, et al.
Publicado: (2022)

Basement membrane components are key players in specialized extracellular matrices
por: Kruegel, Jenny, et al.
Publicado: (2010)

Transcriptomic differences between fibrotic and non-fibrotic testicular tissue reveal possible key players in Klinefelter syndrome-related testicular fibrosis
por: Willems, Margo, et al.
Publicado: (2022)

Non-Coding RNAs of Extracellular Vesicles: Key Players in Organ-Specific Metastasis and Clinical Implications
por: Jiang, Qian, et al.
Publicado: (2022)

Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases
por: Zhu, Junyan, et al.
Publicado: (2023)

Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management
por: Kouranos, Vasileios, et al.
Publicado: (2017)

Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies
por: Diazzi, Serena, et al.
Publicado: (2020)

Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases
por: Huang, Yuling, et al.
Publicado: (2021)

The Role of miRNAs in Extracellular Matrix Repair and Chronic Fibrotic Lung Diseases
por: Usman, Kauna, et al.
Publicado: (2021)

Cell non-autonomous functions of S100a4 drive fibrotic tendon healing
por: Ackerman, Jessica E, et al.
Publicado: (2019)

Role of Ferroptosis in Fibrotic Diseases
por: Zhou, Jian, et al.
Publicado: (2022)

Extracellular Vesicles in Bone Metastasis: Key Players in the Tumor Microenvironment and Promising Therapeutic Targets
por: Tamura, Takaaki, et al.
Publicado: (2020)

Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses
por: Mahmoudvand, Shahab, et al.
Publicado: (2022)

Cyclophilin A: a key player for human disease
por: Nigro, P, et al.
Publicado: (2013)

Emerging role of HMGB1 in fibrotic diseases
por: Li, Liu-Cheng, et al.
Publicado: (2014)

Hoxa5: A Key Player in Development and Disease
por: Jeannotte, Lucie, et al.
Publicado: (2016)

Microbiota, a key player in alcoholic liver disease
por: Cassard, Anne-Marie, et al.
Publicado: (2018)

FADD as a key molecular player in cancer progression
por: Liu, Ying, et al.
Publicado: (2022)

The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases
por: Sattar, Zeeshan, et al.
Publicado: (2021)

Mitochondrial dysfunction in fibrotic diseases
por: Li, Xinyu, et al.
Publicado: (2020)

Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
por: Cox, Thomas R., et al.
Publicado: (2011)

Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?
por: Song, Kai, et al.
Publicado: (2015)

SIRT1: A Key Player in Male Reproduction
por: Khawar, Muhammad Babar, et al.
Publicado: (2022)

Targeting cullin neddylation for cancer and fibrotic diseases
por: He, Zhang-Xu, et al.
Publicado: (2023)

Bile Acids: Key Players in Inflammatory Bowel Diseases?
por: Kriaa, Aicha, et al.
Publicado: (2022)

T Cells in Atherosclerosis: Key Players in the Pathogenesis of Vascular Disease
por: Hinkley, Hannah, et al.
Publicado: (2023)

MiRNA-146a—A Key Player in Immunity and Diseases
por: Gilyazova, Irina, et al.
Publicado: (2023)

Extracellular microRNAs: key players to explore the outcomes of in vitro fertilization
por: Khan, Haroon Latif, et al.
Publicado: (2021)

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
por: Li, Zhenzhen, et al.
Publicado: (2021)

Circular RNAs in cancer: an emerging key player
por: Dong, Yeping, et al.
Publicado: (2017)

Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases
por: Blokland, Kaj E.C., et al.
Publicado: (2020)

Extracellular Matrix, a Hard Player in Angiogenesis
por: Mongiat, Maurizio, et al.
Publicado: (2016)

Immunosenescence: a key player in cancer development
por: Lian, Jingyao, et al.
Publicado: (2020)

The Apoplast: A Key Player in Plant Survival
por: Farvardin, Atefeh, et al.
Publicado: (2020)

Prevotella: A Key Player in Ruminal Metabolism
por: Betancur-Murillo, Claudia Lorena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mnlm206t5qc0u1pn1ucv97frt4